Skip to main content

Table 1 Baseline characteristics

From: A day-to-day management model improves patient compliance to treatment for Helicobacter pylori infection: a prospective, randomized controlled study

 

DTD group

(n = 127)

OE group

(n = 127)

P value

Gender (male)

62 (48.8)

59 (46.5)

0.706

Age (years)

34.0 (28.0, 44.0)

36.0 (29.0, 51.0)

0.159

Body mass index (kg/m2)

22.9 (20.6, 25.4)

22.6 (20.7, 25.2)

0.674

Education status (college or more)

84 (66.1)

81 (63.8)

0.693

Smoking

24 (18.9)

17 (13.4)

0.233

Drinking

38 (29.9)

42 (33.1)

0.589

Symptoms present before treatment

50 (39.4)

52 (40.9)

0.798

Comorbidity

13 (10.2)

18 (14.2)

0.338

Family history of gastric cancer

8 (6.3)

5 (3.9)

0.393

Washing hands before meals

96 (75.6)

102 (80.3)

0.364

Sharing a toothbrush cup

17 (13.4)

25 (19.7)

0.177

Knowing H. pylori is contagious

92 (72.4)

92 (72.4)

1.000

Knowing H. pylori eradication drugs

24 (18.9)

34 (26.8)

0.135

Knowing H. pylori eradication course

29 (22.8)

38 (29.9)

0.200

Knowing the timing of the review UBT

23 (18.1)

23 (18.1)

1.000

  1. DTD, day-to-day; OE, outpatient education; UBT, urea breath test
  2. Values are shown as numbers (percentages) or median (interquartile range)